Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...

Innovation, institutions, integration, and infrastructure are the four key factors that will drive this sector ...

As global markets navigate a mixed economic landscape marked by declining consumer confidence and fluctuating indices, technology stocks continue to capture attention with their potential for high ...

Livewire rounded up 10 of Australia's brightest investment minds for their top growth stock picks for the year ahead.

Sullivan's visit comes as tension is brewing between India and China over Beijing's plan to build what it calls the "world's ...

To select stocks with long-term growth potential, investors should focus on fundamental analysis, evaluating financial health ...

In its Q3 2024 investor letter, Polaris Global Equity Strategy discussed the strong performance of the US biopharma sector, ...

An investment syndicate has hailed investment into 'some of Scotland’s best' early-stage technology and life science companies ...

the global pandemic has strengthened Ireland’s position as a hub for biopharma in Europe. This is due to the need to ensure ‘geographic resilience’ across supply chains, and companies re ...

The BD+C editorial team asked the 2024 Architecture Giants to submit their single-biggest firm innovation or business move ...

Software Defined capabilities, which originated with cloud technology, will be powered by AI & ML and make informed decisions among six trends ...

Building UK pandemic resilience At its outset ... For anyone who works in the biopharma industry, they will know just how expensive it is to keep a facility running, and the option for having ...